4-苯氧基-苯丙醛 | 54954-44-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-苯氧基-苯丙醛
• 英文名称: 3-(4-phenoxyphenyl)propanal
• 英文别名: 3-(4-Phenoxy-phenyl)-propionaldehyd；3-(4-phenoxyphenyl)-propan-1-al；4-Phenoxy-benzenepropanal
• CAS: 54954-44-8
• 化学式: C₁₅H₁₄O₂
• 分子量: 226.275
• InChiKey: YWWSTWLNICEXHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-苯氧基-苯丙醛 在 hydroxylamine resin 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 3-(3-cyclopentyloxy-4-methoxyphenylsulfonyl)-5-(4-phenoxyphenyl)-pentanohydroxamic acid
  参考文献：
  名称：

  Solid-phase synthesis of an arylsulfone hydroxamate library

  摘要：

  Synthesis of an arylsulfone hydroxamate lead optimization library is presented. Biological activity of representative examples is given to demonstrate the value of this approach for lead optimization. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00285-7
• 作为产物：
  描述：

  3-(4-苯氧基苯基)丙酸乙酯 在 二异丁基氢化铝 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 反应 2.0h， 以81%的产率得到4-苯氧基-苯丙醛
  参考文献：
  名称：

  Optimization of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase

  摘要：

  A series of alpha-ketooxazoles containing conformational constraints in the flexible C2 acyl side chain of 2 (OL-135) and representative oxazole C5 substituents were prepared and examined as inhibitors of fatty acid amide hydrolase (FAAH). Exceptionally potent and selective FAAH inhibitors emerged from the series (e.g., 6, K-i = 200 and 260 pM for rat and rhFAAH). With simple and small C5 oxazole substituents, each series bearing a biphenylethyl, phenoxyphenethyl, or (phenoxymethyl)phenethyl C2 side chain was found to follow a well-defined linear relationship between -log K-i and Hammett sigma(p) of a magnitude (rho = 2.7-3.0) that indicates that the substituent electronic effect dominates, confirming its fundamental importance to the series and further establishing its predictive value. Just as significantly, the nature of the C5 oxazole substituent substantially impacts the selectivity of the inhibitors whereas the effect of the C2 acyl chain was more subtle but still significant even in the small series examined. Combination of these independent features, which display generalized trends across a range of inhibitor series, simultaneously improves FAAH potency and selectivity and can provide exquisitely selective and potent FAAH inhibitors.

  DOI：

  10.1021/jm701210y

文献信息

• Diarylhydroxy alkanones and alkenones antiallergy agents
  申请人：USV Pharmaceutical Corp.

  公开号：US04567279A1

  公开（公告）日：1986-01-28

  This invention relates to new chemical compounds which possess valuable therapeutic activity particularly as lipoxygenase inhibitors possessing antiflammatory and antiallergic properties. The present new compounds are of the formula: ##STR1## wherein, Z and Z.sub.1 each are alkylene chains containing up to three carbon atoms in the principal chain and a total of up to five carbon atoms and include from 0-1 double bonds; R is H or lower alkyl; R.sub.1 and R.sub.2 each are H, lower alkyl, OH, lower alkoxy, benzyloxy, carboxy, alkylenecarboxyl or alkylcarbonyl. R.sub.3 is H, lower alkyl, aralkyl or lower alkanoyl; and X is --O(CH.sub.2).sub.n --, --CH.dbd.CH--, --(CH.sub.2).sub.n --, --S(CH.sub.2).sub.n -- or ##STR2## n=0 or 1 n'=1 or 2.

  本发明涉及新的化合物，其具有有价值的治疗活性，特别是作为脂氧合酶抑制剂具有抗炎和抗过敏特性。目前的新化合物的化学式为：##STR1## 其中，Z和Z.sub.1分别是含有主链中最多三个碳原子和总共最多五个碳原子的烷基链，包括0-1个双键；R为H或较低的烷基；R.sub.1和R.sub.2分别为H、较低的烷基、OH、较低的烷氧基、苄氧基、羧基、烷基羧酸或烷基羰基。R.sub.3为H、较低的烷基、芳基烷基或较低的烷酰基；X为--O(CH.sub.2).sub.n --、--CH.dbd.CH--、--(CH.sub.2).sub.n --、--S(CH.sub.2).sub.n --或##STR2## n=0或1，n'=1或2。
• Zeolites as equilibrium-shifting agents in shuttle catalysis
  作者：Jesse Dallenes、Jonas Wuyts、Niels Van Velthoven、Andraž Krajnc、Gregor Mali、Oleg A. Usoltsev、Aram L. Bugaev、Dirk De Vos

  DOI：10.1038/s41929-023-00967-8

  日期：——

  we show an approach that harnesses the shape-selective and catalytic properties of zeolites to drive the shuttling equilibrium of transfer hydrocyanation and transfer hydroformylation reactions to near-completion. The zeolites irreversibly convert the transfer reaction co-products in an exergonic tandem reaction while excluding the substrates via pore size restrictions. Through fine-tuning of the zeolite’s

  功能部分的催化穿梭已成为替代和多样化传统氢化功能化技术的有前途的策略。然而，由于它们的等渗性质，这些反应是可逆的，这限制了它们对选定的供体和受体分子阵列的适用性，并在原子经济性和实用性方面提出了重大挑战。在这里，我们展示了一种利用沸石的形状选择性和催化特性来驱动转移氢氰化和转移加氢甲酰化反应接近完成的穿梭平衡的方法。沸石在放能串联反应中不可逆地转化转移反应副产物，同时通过孔径限制排除底物。通过微调沸石的特性，可以实现高达 80% 的产率增加，从而使腈供体多样化为丙腈，醛受体多样化为未活化的烯烃。机械和光谱研究突出了沸石和均相转移催化剂之间独特的协同作用。
• Diarylhydroxy alkanones and alkanones antiallergy agents
  申请人：USV PHARMACEUTICAL CORPORATION

  公开号：EP0184853A2

  公开（公告）日：1986-06-18

  This invention relates to new chemical compounds which possess valuable therapeutic activity particularly as lipoxygenase inhibitors possessing antiflammatory and antiallergic properties. The present new compounds are of the formula wherein, Z and Z, each are alkylene chains containing up to three carbon atoms in the principal chain and a total of up to five carbon atoms and include from 0-1 double bonds; R is H or lower alkyl; R, and R, each are H, lower alkyl, OH, lower alkoxy, benzyloxy, carboxy, alkylenecarboxy or alkylcarbonyl. R, IS H, lower alkyl, aralkyl or lower alkanoyl; and X IS -O(CH2)n -, -CH =CH-, - (CH2)n -, -S(CH2)n- or

  本发明涉及具有重要治疗活性的新化合物，特别是作为具有抗炎和抗过敏特性的脂氧合酶抑制剂。本发明的新化合物的化学式为 其中 Z 和 Z，各自为亚烷基链，在主链中最多含有三个碳原子，总共最多含有五个碳原子，包括 0-1 个双键； R 是 H 或低级烷基； R，和 R，各自是 H、低级烷基、OH、低级烷氧基、苄氧基、羧基、亚烷基羧基或 烷基羰基。 R，IS H、低级烷基、芳基或低级烷酰基；以及 X IS -O(CH2)n-, -CH =CH-, - (CH2)n-, -S(CH2)n- 或
• CHAN, WAN-KIT
  作者：CHAN, WAN-KIT

  DOI：——

  日期：——
• TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF
  申请人：THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK

  公开号：EP0966456B1

  公开（公告）日：2003-04-02